112 related articles for article (PubMed ID: 8310712)
21. The analysis and disposition of imipramine and its active metabolites in man.
Sutfin TA; DeVane CL; Jusko WJ
Psychopharmacology (Berl); 1984; 82(4):310-7. PubMed ID: 6427820
[TBL] [Abstract][Full Text] [Related]
22. Catalysis of drug oxidation during embryogenesis in human hepatic tissues using imipramine as a model substrate.
Chen H; Brzezinski MR; Fantel AG; Juchau MR
Drug Metab Dispos; 1999 Nov; 27(11):1306-8. PubMed ID: 10534316
[TBL] [Abstract][Full Text] [Related]
23. Metabolic disposition of imipramine in oriental subjects: relation to metoprolol alpha-hydroxylation and S-mephenytoin 4'-hydroxylation phenotypes.
Koyama E; Sohn DR; Shin SG; Chiba K; Shin JG; Kim YH; Echizen H; Ishizaki T
J Pharmacol Exp Ther; 1994 Nov; 271(2):860-7. PubMed ID: 7965806
[TBL] [Abstract][Full Text] [Related]
24. The Use of In Vitro Data and Physiologically-Based Pharmacokinetic Modeling to Predict Drug Metabolite Exposure: Desipramine Exposure in Cytochrome P4502D6 Extensive and Poor Metabolizers Following Administration of Imipramine.
Nguyen HQ; Callegari E; Obach RS
Drug Metab Dispos; 2016 Oct; 44(10):1569-78. PubMed ID: 27440861
[TBL] [Abstract][Full Text] [Related]
25. Metabolism of methoxyphenamine in vitro by a CYP2D6 microsomal preparation.
Coutts RT; Bolaji OO; Su P; Baker GB
Drug Metab Dispos; 1994; 22(5):756-60. PubMed ID: 7835228
[TBL] [Abstract][Full Text] [Related]
26. Effect of ketoconazole on the pharmacokinetics of imipramine and desipramine in healthy subjects.
Spina E; Avenoso A; Campo GM; Scordo MG; Caputi AP; Perucca E
Br J Clin Pharmacol; 1997 Mar; 43(3):315-8. PubMed ID: 9088587
[TBL] [Abstract][Full Text] [Related]
27. Reappraisal of human CYP isoforms involved in imipramine N-demethylation and 2-hydroxylation: a study using microsomes obtained from putative extensive and poor metabolizers of S-mephenytoin and eleven recombinant human CYPs.
Koyama E; Chiba K; Tani M; Ishizaki T
J Pharmacol Exp Ther; 1997 Jun; 281(3):1199-210. PubMed ID: 9190854
[TBL] [Abstract][Full Text] [Related]
28. The N-demethylation of imipramine correlates with the oxidation of S-mephenytoin (S/R-ratio). A population study.
Skjelbo E; Gram LF; Brøsen K
Br J Clin Pharmacol; 1993 Mar; 35(3):331-4. PubMed ID: 8471415
[TBL] [Abstract][Full Text] [Related]
29. In vitro microsomal metabolism of imipramine under conditions mimicking the in vivo steady-state situation.
Linnet K
Hum Psychopharmacol; 2004 Jan; 19(1):31-6. PubMed ID: 14716709
[TBL] [Abstract][Full Text] [Related]
30. Kinetic properties of the metabolism of imipramine and desipramine in isolated rat hepatocytes.
Chiba M; Fujita S; Suzuki T
Biochem Pharmacol; 1990 Jan; 39(2):367-72. PubMed ID: 2302258
[TBL] [Abstract][Full Text] [Related]
31. Determination of imipramine and seven of its metabolites in human liver microsomes by a high-performance liquid chromatographic method.
Zeugin TB; Brosen K; Meyer UA
Anal Biochem; 1990 Aug; 189(1):99-102. PubMed ID: 2278396
[TBL] [Abstract][Full Text] [Related]
32. Plasma levels of imipramine and metabolites in 68 hospitalized children.
Preskorn SH; Bupp SJ; Weller EB; Weller RA
J Am Acad Child Adolesc Psychiatry; 1989 May; 28(3):373-5. PubMed ID: 2738003
[TBL] [Abstract][Full Text] [Related]
33. Imipramine for Cytochrome P450 Activity Determination: a Multiple-species Metabolic Probe.
Bull S; Catalani P; Garle M; Coecke S; Clothier R
Toxicol In Vitro; 1999; 13(4-5):537-41. PubMed ID: 20654512
[TBL] [Abstract][Full Text] [Related]
34. The effect of imipramine and desipramine on mixed function oxidase in rats.
Daniel W; Friebertshäuser J; Steffen C
Naunyn Schmiedebergs Arch Pharmacol; 1984 Nov; 328(1):83-6. PubMed ID: 6440032
[TBL] [Abstract][Full Text] [Related]
35. Eight inhibitory monoclonal antibodies define the role of individual P-450s in human liver microsomal diazepam, 7-ethoxycoumarin, and imipramine metabolism.
Yang TJ; Krausz KW; Sai Y; Gonzalez FJ; Gelboin HV
Drug Metab Dispos; 1999 Jan; 27(1):102-9. PubMed ID: 9884317
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of cytochrome P450 2D6-catalyzed sparteine metabolism in humans.
Ebner T; Meese CO; Eichelbaum M
Mol Pharmacol; 1995 Dec; 48(6):1078-86. PubMed ID: 8848008
[TBL] [Abstract][Full Text] [Related]
37. Inhibition and induction of cytochrome P450 isozymes after repetitive administration of imipramine in rats.
Masubuchi Y; Takahashii C; Fujio N; Horie T; Suzuki T; Imaoka S; Funae Y; Narimatsu S
Drug Metab Dispos; 1995 Sep; 23(9):999-1003. PubMed ID: 8565792
[TBL] [Abstract][Full Text] [Related]
38. Activation and deactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by cytochrome P450 enzymes and flavin-containing monooxygenases in common marmosets (Callithrix jacchus).
Uehara S; Uno Y; Inoue T; Murayama N; Shimizu M; Sasaki E; Yamazaki H
Drug Metab Dispos; 2015 May; 43(5):735-42. PubMed ID: 25735838
[TBL] [Abstract][Full Text] [Related]
39. Phe120 contributes to the regiospecificity of cytochrome P450 2D6: mutation leads to the formation of a novel dextromethorphan metabolite.
Flanagan JU; Maréchal JD; Ward R; Kemp CA; McLaughlin LA; Sutcliffe MJ; Roberts GC; Paine MJ; Wolf CR
Biochem J; 2004 Jun; 380(Pt 2):353-60. PubMed ID: 14992686
[TBL] [Abstract][Full Text] [Related]
40. The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron.
Fischer V; Vickers AE; Heitz F; Mahadevan S; Baldeck JP; Minery P; Tynes R
Drug Metab Dispos; 1994; 22(2):269-74. PubMed ID: 8013282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
